GlassScriptPhysician profile
Jeremiah Lee Deneve
NPI 1043373038
$2,991.49
in general payments reported to CMS, 2019-2025
12 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $94.34 · 2021: $122 · 2022: $109 · 2023: $325 · 2024: $1,017 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905 · Travel and Lodging: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.54 |
| Travel and Lodging | $641.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $641.15 | 2025 | |
| Acera Surgical, INC. | $440.63 | 2021-2024 | Restrata Wound Matrix |
| Delcath Systems | $425.41 | 2024-2025 | Hepzato Kit |
| Ethicon US, LLC | $376.99 | 2020-2024 | Certus 140, Surgicel Nu-Knit, Harmonic |
| Intera Oncology, INC | $365.44 | 2024-2025 | Intera |
| Springworks Therapeutics, INC. | $226.36 | 2024 | Ogsiveo |
| Baxter Healthcare | $130.69 | 2025 | Tisseel |
| Caris Mpi, INC. | $130.28 | 2025 | Mi Cancer Seek |
| W. L. Gore & Associates, INC. | $120.43 | 2019 | |
| Medical Device Business Services, INC. | $73.95 | 2025 | Echelon Flex |
| Integra Lifesciences Corporation | $42.11 | 2023 | Integra, Surgimend, Omnigraft |
| Medtronic, INC. | $18.05 | 2025 | Emprint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Deneve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.